Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | 2,6-dimethylpiperidine | 19009 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | 2,6-dimethylpiperidine | 19009 | drug-path |
Cell cycle | R-HSA-1640170 | map04110 | 2,6-dimethylpiperidine | 19009 | drug-path |
Asthma | R-HSA-444620 | map05310 | 2,6-dimethylpiperidine | 19009 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | 2,6-dimethylpiperidine | 19009 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | 2,6-dimethylpiperidine | 19009 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | 2,6-dimethylpiperidine | 19009 | drug-path |
Glioma | Q9NZM4 | map05214 | 2,6-dimethylpiperidine | 19009 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | 2,6-dimethylpiperidine | 19009 | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | 2,6-dimethylpiperidine | 19009 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | 2,6-dimethylpiperidine | 19009 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | 2,6-dimethylpiperidine | 19009 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | 2,6-dimethylpiperidine | 19009 | drug-path |
Chronic myeloid leukemia | R-HSA-9680350 | map05220 | 2,6-dimethylpiperidine | 19009 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | ciclacillin | 71415 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | ciclacillin | 71415 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | ciclacillin | 71415 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | ciclacillin | 71415 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | ciclacillin | 71415 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | ciclacillin | 71415 | drug-path |